Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.aller.2018.10.003 http://scihub22266oqcxt.onion/10.1016/j.aller.2018.10.003 30595390!7125869!30595390     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 263.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 263.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 263.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Allergol+Immunopathol+(Madr) 2019 ; 47 (3): 282-288 Nephropedia Template TP {{tp|p=30595390|t=2019. Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study |pdf=|usr=}}{{30595390}} gab.com Text Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study JO: Allergol Immunopathol (Madr) http://www.kidney.de/pget.php?&tw=1&pmid=30595390 #FOAvip OBJECTIVE: To describe potential regional variations in therapies for severe asthma exacerbations in Chilean children and estimate the associated health expenditures. METHODS: Observational prospective cohort study in 14 hospitals over a one-year period. Children five years of age or older were eligible for inclusion. Days with oxygen supply and pharmacological treatments received were recorded from the clinical chart. A basic asthma hospitalization basket was defined in order to estimate the average hospitalization cost for a single patient. Six months after discharge, new visits to the Emergency Room (ER), use of systemic corticosteroids and adherence to the controller treatment were evaluated. RESULTS: 396 patients were enrolled. Patients from the public health system and from the north zone received significantly more days of oxygen, systemic corticosteroids and antibiotics. Great heterogeneity in antibiotic use among the participating hospitals was found, from 0 to 92.3% (ICC 0.34, 95% CI 0.16-0.52). The use of aminophylline, magnesium sulfate and ketamine varied from 0 to 36.4% between the different Pediatric Intensive Care Units (ICC 0.353, 95% CI 0.010-0.608). The average cost per inpatient was of $1910 USD. 290 patients (73.2%) completed the follow-up six months after discharge. 76 patients (26.2%) were not receiving any controller treatment and nearly a fourth had new ER visits and use of systemic corticosteroids due to new asthma exacerbations. CONCLUSIONS: Considerable practice variation in asthma exacerbations treatment was found among the participating hospitals, highlighting the poor outcome of many patients after hospital discharge, with an important health cost. Twit Text FOAVip Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study ????Allergol Immunopathol (Madr) http://www.kidney.de/pget.php?&tw=1&pmid=30595390 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30595390 #FOAvip English Wikipedia <ref>{{Cite pmid|30595390}}</ref> Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study #MMPMID30595390 Herrera AM; Brand P; Cavada G; Koppmann A; Rivas M; Mackenney J; Sepulveda H; Wevar ME; Cruzat L; Soto S; Perez MA; Leon A; Contreras I; Alvarez C; Walker B; Flores C; Lezana V; Garrido C; Herrera ME; Rojas A; Andrades C; Chala E; Martinez RA; Vega M; Perillan JA; Seguel H; Przybyzsweski I Allergol Immunopathol (Madr) 2019[May]; 47 (3): 282-288 PMID30595390show ga OBJECTIVE: To describe potential regional variations in therapies for severe asthma exacerbations in Chilean children and estimate the associated health expenditures. METHODS: Observational prospective cohort study in 14 hospitals over a one-year period. Children five years of age or older were eligible for inclusion. Days with oxygen supply and pharmacological treatments received were recorded from the clinical chart. A basic asthma hospitalization basket was defined in order to estimate the average hospitalization cost for a single patient. Six months after discharge, new visits to the Emergency Room (ER), use of systemic corticosteroids and adherence to the controller treatment were evaluated. RESULTS: 396 patients were enrolled. Patients from the public health system and from the north zone received significantly more days of oxygen, systemic corticosteroids and antibiotics. Great heterogeneity in antibiotic use among the participating hospitals was found, from 0 to 92.3% (ICC 0.34, 95% CI 0.16-0.52). The use of aminophylline, magnesium sulfate and ketamine varied from 0 to 36.4% between the different Pediatric Intensive Care Units (ICC 0.353, 95% CI 0.010-0.608). The average cost per inpatient was of $1910 USD. 290 patients (73.2%) completed the follow-up six months after discharge. 76 patients (26.2%) were not receiving any controller treatment and nearly a fourth had new ER visits and use of systemic corticosteroids due to new asthma exacerbations. CONCLUSIONS: Considerable practice variation in asthma exacerbations treatment was found among the participating hospitals, highlighting the poor outcome of many patients after hospital discharge, with an important health cost. |*Cost of Illness[MESH] |Adrenal Cortex Hormones/*therapeutic use[MESH] |Asthma/drug therapy/economics/*epidemiology[MESH] |Child[MESH] |Chile/epidemiology[MESH] |Cohort Studies[MESH] |Disease Progression[MESH] |Emergency Medical Services[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Hospitalization[MESH] |Humans[MESH] |Male[MESH] |Prospective Studies[MESH]Treatment, outcomes and costs of asthma exacerbations in Chilean child(epmc).pdf DeepDyve Pubget Overpricing